Lioresal in the treatment of spasticity
Duma-Drzewińska, A.; Kiwerski, J.; Makowski, J.
Polski Tygodnik Lekarski 31(29): 1259-1262
1976
ISSN/ISBN: 0032-3756 PMID: 948473 Document Number: 104585
Document emailed within 1 workday
Related Documents
Ketelaer, P.; Tyberghein, J.M.; Ketelaer, C.J. 1973: C34.647-Ba (Lioresal) in the treatment of hypertonic manifestations of multiple sclerosis Bruxelles Medical 53(11): 675-681Musioł, A.; Kazibutowska, Z.; Kurzbauer, H. 1977: Lioresal in the treatment of hemiplegia. Clinical and electromyographic evaluation. Preliminary report Neurologia i Neurochirurgia Polska 11(6): 661-667
Autti-Rämö, I. 1999: Treatment of spasticity Duodecim; Laaketieteellinen Aikakauskirja 115(8): 877-885
Jelasic, F. 1974: Drug treatment of spasticity Münchener Medizinische Wochenschrift 116(16): 851-854
Hjemdahl, P. 1974: Lioresal (Baclofen, Ciba) Lakartidningen 71(26): 2603
Ward, A.B. 2008: Botulinum toxin in spasticity treatment in adults Der Nervenarzt 79(Suppl 1): 22-23
Morota, N. 2010: Functional posterior rhizotomy for treatment of spasticity No Shinkei Geka. Neurological Surgery 38(3): 209-228
Smith, P.F. 2002: Cannabinoids in the treatment of pain and spasticity in multiple sclerosis Current Opinion in Investigational Drugs 3(6): 859-864
Mack, R.B. 1995: Between a rock and a Charybdisian place. Baclofen (Lioresal) overdose North Carolina Medical Journal 56(7): 325-327
Viriyavejakul, A.; Vachalathiti, R.; Poungvarin, N. 1998: Botulinum treatment for post-stroke spasticity: low dose regime Journal of the Medical Association of Thailand 81(6): 413-422
García-Castro, J.M. 1977: Dantrolene sodium: an effective therapeutic agent for the treatment of spasticity in children Boletin de la Asociacion Medica de Puerto Rico 69(8): 263-265
Vásquez-Briceño, A.; Arellano-Saldaña, M.E.; León-Hernández, S.R.; Morales-Osorio, M.G. 2006: The usefulness of tizanidine. a one-year follow-up of the treatment of spasticity in infantile cerebral palsy Revista de Neurologia 43(3): 132-136
Levine, I.M.; Jossmann, P.B.; DeAngelis, V. 1977: Liorseal, a new muscle relaxant in the treatment of spasticity--a double-blind quantitative evaluation Diseases of the Nervous System 38(12): 1011-1015
Wolswijk, A.H.M.; Dirkx, A.E.M. 2015: Treatment of spasticity in nursing homes: botulinum toxin type a as part of therapy Nederlands Tijdschrift Voor Geneeskunde 159: A7833
Opara, Józef.; Hordyńska, E.; Swoboda, A. 2007: Effectiveness of botulinum toxin A in the treatment of spasticity of the lower extremities in adults - preliminary report Ortopedia, Traumatologia, Rehabilitacja 9(3): 277-285
Saltuari, L.; Kronenberg, M.; Marosi, M.J.; Kofler, M.; Russegger, L.; Rifici, C.; Bramanti, P.; Gerstenbrand, F. 1992: Indication, efficiency and complications of intrathecal pump supported baclofen treatment in spinal spasticity Acta Neurologica 14(3): 187-194
Lazareff, J.A.; Mata-Acosta, A.M.; García-Méndez, M.A.; Escanero-Salazar, A. 1990: Selective limited posterior rhizotomy at 3 dorsal levels. A variant for the neurosurgical treatment of spasticity Boletin Medico del Hospital Infantil de Mexico 47(2): 72-77
Smolenski, C.; Muff, S.; Smolenski-Kautz, S. 1981: A double-blind comparative trial of new muscle relaxant, tizanidine (DS 103-282), and baclofen in the treatment of chronic spasticity in multiple sclerosis Current Medical Research and Opinion 7(6): 374-383
Saulino, M. 2012: Simultaneous treatment of intractable pain and spasticity: observations of combined intrathecal baclofen-morphine therapy over a 10-year clinical experience European Journal of Physical and Rehabilitation Medicine 48(1): 39-45
Takebe, K.; Kukulka, C.G.; Narayan, M.G.; Basmajian, J.V. 1976: Biofeedback treatment of foot drop after stroke compared with standard rehabilitation technique (part 2): effects on nerve conduction velocity and spasticity Archives of Physical Medicine and Rehabilitation 57(1): 9-11